Synopsis
Rakesh Jhunjhunwala’s recent portfolio restructuring saw many of his wealth creators losing weightage and new stocks being added to his portfolio.
ETMarkets.com
Rakesh Jhunjhunwala and his wife went light on three stocks while adding two more to their kitty.
Investing as a career is to let the company’s management constantly worry about running the business while you just let yourself sit back and sip wine, says veteran value investor Vijay Kedia. He seems to correctly point at investors doing just the opposite and inviting unhappiness by adding unnecessary parameters. Read about Kedia’s simple yet successful take on investing, Rakesh Jhunjhunwala’s portfolio restructuring, Samir Arora taking shots at popular beliefs from people like Warren Buffet, and more in this week’s ‘Long & Short of Markets’.
Explore Now
NEW DELHI: Ace investor Rakesh Jhunjhunwala significantly increased his holding in hospital chain Fortis Healthcare in the March quarter, as per data released by the company.
The data, released on Tuesday, shows the Big Bull bought 1.25 crore shares of the company, raising his holding to 4.31 per cent at the end of the March quarter, from 2.65 per cent in the previous quarter.
As of Monday s close, his holding in the company is valued at Rs 671 crore.
Rakesh Jhunjhunwala bought shares worth Rs 260 crore in the March quarter, as of the current price.
Fortis Healthcare shares, however, declined over 2% in afternoon trade on Tuesday following a positive opening.
NEW DELHI: The domestic equity market has turned volatile as Dalal Street waits for half-a-dozen primary market offerings to hit the market this week.
IPO watchers say the Rakesh Jhunjhunwala-backed Nazara Technologies is likely to be the showstopper of the season, and that is exactly what the grey market is signaling at this point.
The premia on the unlisted shares trading in the grey market have plunged significantly for the other IPOs – Anupam Rasayan, Kalyan Jewellers, Laxmi Organics, Craftsman Automations and Suryoday Small Finance Bank.
But shares of the mobile gaming firm have been surging in the unofficial market, with the premium over the IPO price soaring as much as Rs 840-850 per share.
Synopsis
ETMarkets.com
Rakesh Jhunjhunwala
The butterfly effect of rising bond yields sent shock waves across the global stock market last week. Inflation, being the villain here, can force central banks globally to raise interest rates which can prove fatal for the bull run. Read about the threat from bonds, Rakesh Jhunjhunwala’s gauge to predict bull market’s demise, his commodity bets and more in this weekend’s edition of ‘Long & Short of Markets’.
When will bulls retreat
In this interview, Rakesh Jhunjhunwala gives two other reasons, apart from interventions by central banks, that can lead to the death of a bull market. Read here for more on Big Bull’s take on the end of a bull run, reasons behind his bullishness on Tata Group stocks and his thoughts on the ongoing commodity boom.
Rakesh Jhunjhunwala, Partner,
Rare Enterprises, in an interview with Nikunj Dalmia of ET NOW.
Can I quote your favourite line, that bull markets are born on pessimism, grow on scepticism, mature on optimism and die on euphoria?
I do not think these are my words. I think these are the John Templeton. But what he is saying is absolutely right.
If this bull market is a journey from Churchgate to Borivali, where do you think this bull market has reached?
I would say Charni Road.
So it has a long, long way to go?
Yes.
Do you see the potential of a kind of raging bull market in India like we saw in America last decade?